Tryp Therapeutics, Inc. (CSE: TRYP OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases...
Source: Streetwise Reports 09/12/2022 One biopharma co. is teaming with a much larger pharmaceutical company to develop a fast-dissolving...
The article Algernon Pharmaceuticals Receives Approval for Phase 1 DMT Study was originally published on Microdose. For more on Algernon and their DMT...
Source: Streetwise Reports 09/04/2022 One small-cap pharma co. just published more good news on a possible treatment for patients suffering...
Core One Labs Inc. (CSE:COOL | OTCQB:CLABF | Frankfurt:LD6 | WKN:A3CSSU) is pleased to announce that scientists at its wholly-owned subsidiary Awakened...
Core One Labs Inc. (CSE: COOL | OTCQB: CLABF), (Frankfurt: LD6, WKN: A3CSSU) announces that it has initiated rollout of its commercial sales strategy...
The article Mydecine Sells Mindleap Health for $4 Million was originally published on Microdose. We’ve been reporting on the apparent troubles over...
Mydecine sells Mindleap and gets a much-needed cash infusion. The post Mydecine Sells Mindleap For C$4 Million appeared first on Green Market Report.